eIF3 θ Antibodies

Santa Cruz Biotechnology provides a broad selection of eIF3 θ monoclonal antibodies for a variety of research applications. eIF3 θ Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 θ, a critical component of the eukaryotic translation initiation factor 3 complex, plays a vital role in the regulation of protein synthesis. It is involved in the recruitment of mRNA and the assembly of the ribosomal subunits, making it essential for cellular growth and proliferation. Dysregulation of eIF3 θ has been implicated in various diseases, including cancer, highlighting its importance as a target for therapeutic intervention. Research into eIF3 θ continues to reveal new insights about translation initiation mechanisms and potential therapeutic strategies. Understanding eIF3 θ function is crucial for advancing knowledge in molecular biology and disease treatment. Santa Cruz Biotechnology monoclonal antibodies for eIF3 θ enable researchers worldwide to advance scientific understanding of translation initiation and its role in human health.